View Thomas Barron's Full Profile >>
Photo of: Thomas Barron

Thomas I. Barron

View Title...

Trinity College Dublin
Dublin, Ireland
Thomas's profile was created using:
Sort By:

1-4 of 4 online sources for Thomas Barron

  • View Online Source
    www.cancerfacts.com/Home_News.asp?NewsId=2122&CB=14&Can - [Cached Version]
    Published on: 1/22/2007    Last Visited: 3/1/2007  

    Led by Thomas I. Barron, of the Department of Pharmacology & Therapeutics at Trinity College Dublin & St James's Hospital, Dublin, researchers reviewed pharmaceutical data from a national database of 2816 women aged 35 years and older who started tamoxifen for breast cancer.

  • View Online Source
    www.vidyya.com/vol9/v9i22_2.htm - [Cached Version]
    Published on: 1/22/2007    Last Visited: 3/11/2007  

    Led by Thomas I. Barron, M.Sc. of the Department of Pharmacology & Therapeutics at Trinity College Dublin & St James's Hospital, Dublin, researchers reviewed pharmaceutical data from a national database of 2816 women aged 35 years and older who started tamoxifen for breast cancer.
    ...
    Article: "Early Discontinuation of Tamoxifen: A Lesson for Oncologists," Thomas I. Barron, Róisín M. Connolly, Kathleen Bennett, John Feely, M. John Kennedy, Cancer; Published Online: January 22, 2007

  • View Online Source
    Breast Cancer > Tamoxifen discontinuation rates... - [Cached Version]
    Published on: 7/1/2005    Last Visited: 1/26/2007  

    Led by Thomas I. Barron, M.Sc. of the Department of Pharmacology & Therapeutics at Trinity College Dublin & St James's Hospital, Dublin, researchers reviewed pharmaceutical data from a national database of 2816 women aged 35 years and older who started tamoxifen for breast cancer.

  • View Online Source
    Tamoxifen discontinuation rates surprisingly high in... - [Cached Version]
    Published on: 1/22/2007    Last Visited: 1/22/2007  

    Led by Thomas I. Barron, M.Sc. of the Department of Pharmacology & Therapeutics at Trinity College Dublin & St James's Hospital, Dublin, researchers reviewed pharmaceutical data from a national database of 2816 women aged 35 years and older who started tamoxifen for breast cancer.
    ...
    Article: "Early Discontinuation of Tamoxifen: A Lesson for Oncologists," Thomas I. Barron, Róisín M. Connolly, Kathleen Bennett, John Feely, M. John Kennedy, CANCER; Published Online: January 22, 2007 (DOI: 10.1002/cncr.22486); Print Issue Date: March 1, 2007.

Wrong Person?

Try these instead
More...
For Recruiters For Sales Pros

Products Overview | Add New Company | Add Your Profile | Tools & Resources | Developer API
FAQ | Privacy Policy | Terms of Service | About Us | Contact Us | Jobs at ZoomInfo | Advertise with Us

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM11